PACB - Pacific Biosciences of California Q4 2022 Earnings Preview

• Pacific Biosciences of California ( NASDAQ: PACB ) is scheduled to announce Q4 earnings results on Thursday, February 16th, after market close.
• The consensus EPS Estimate is -$0.37 (-23.3% Y/Y) and the consensus Revenue Estimate is $27.29M (-24.2% Y/Y).
• Over the last 1 year, PACB has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.
• Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 0 upward revisions and 3 downward.

For further details see: